We exist to utilize our multi-target cell and gene therapy platform to develop curative therapies for chronic wound, cancer, and inflammatory disease patients.
Our goal is to create solid clinical safety and efficacy data in Diabetic Foot Ulcer, other chronic wounds and deadly cancers, and to engage with strategic partners to enable market entry to ensure that this game-changing technology platform benefits millions of patients throughout the world.
SCIENTIFIC ADVISORY BOARD
BOARD OF DIRECTORS
Senior Executive Assistant
Do you have any questions to our team? Get in touch.